Conexus, Venezuela’s leading payments processor, plans to integrate Bitcoin and stablecoins like Tether (USDT), into the country’s banking network. The payments giant, which handles roughly 40% of ...
IRVINE, Calif., Jan. 27, 2026 /PRNewswire/ -- Conexus is excited to kick off 2026 with a thoughtful yet aggressive organic growth strategy, expanding into three new markets beyond its current West ...
A large warehouse and industrial site in Solon has been sold by its Beachwood owners to a Chicago-based food distribution company. JLL Managing Director David Stecker said the site sold Dec. 16, for ...
The transaction is expected to close in the first quarter of 2026 Conexus is a service provider for the energy infrastructures Conexus was acquired in 2022 as Sirti Energia Mutares has signed an ...
(RTTNews) - Mutares SE & Co. KGaA (MUX.DE, MUTRF), a Germany-based holding company, on Tuesday announced it has signed an agreement to sell portfolio company Conexus S.p.A. to Advanced Technology ...
Example elevations presented to Monument City Council for Conexus Lot 2. Courtesy of the town of Monument. On Monday, the Monument Town Council unanimously approved a Final Planned Unit Development ...
WAUSAU − Connexus Credit Union has been named one of the best places to work in IT for the second year in a row. The Wausau-based financial institution climbed two spots to No. 12 among small ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Meet 2025 Most Admired CEOs ...
CHESTERFIELD COUNTY, Va. (WRIC) — Conexus brings kids in Richmond-area schools more than just the gift of sight. It also brings the gift of confidence. 8News has partnered with Conexus for its annual ...
A U.S. neurotechnology startup called Paradromics is gaining momentum in the fast-growing field of brain-computer interfaces. The FDA has approved its first human trial built to test whether its fully ...
US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, with the Food and Drug Administration (FDA) green-lighting a human trial to ...